北陸藥業(300016.SZ):海昌藥業股票定向發行新增股份登記
格隆匯11月29日丨北陸藥業(300016.SZ)公佈,公司控股子公司浙江海昌藥業股份有限公司(“海昌藥業”)於2021年9月3日召開2021年第四次臨時股東大會,會議審議通過了《浙江海昌藥業股份有限公司股票定向發行説明書》等議案。
海昌藥業向北京德福資產管理有限公司—德福中國醫療價值投資私募證券投資基金定向發行910萬股股份,募集資金10920萬元,將用於歸還銀行貸款,以優化海昌藥業財務結構,提升盈利能力及抗風險能力,進一步促進海昌藥業主營業務的發展,保障海昌藥業整體經營目標和發展戰略的全面落地。
近日,上述新增股份已完成股權登記相關手續,並將於12月8日起在全國中小企業股份轉讓系統掛牌並公開轉讓。此次發行後,公司持有海昌藥業29.94%的股份,與一致行動人曾春輝合計持有海昌藥業58.64%的股份,海昌藥業實際控制人、控股股東及一致行動人、第一大股東不會發生變化,不會導致公司控制權發生變動。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.